Resolution of headache after reduction of prolactin levels in hyperprolactinemic patients
Autor(a) principal: | |
---|---|
Data de Publicação: | 2020 |
Outros Autores: | , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Arquivos de neuro-psiquiatria (Online) |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2020000100028 |
Resumo: | Abstract Prolactin (PRL) secreting adenomas are associated with high incidence of headache. The role of hyperprolactinemia in the headache context is not clear, nor is the effect of its treatment on headache. Methods: The present longitudinal study evaluated hyperprolactinemic patients (69), in terms of presence and characteristics of headache before and after hyperprolactinemia treatment. Results: Headache was reported by 45 (65.2%) patients, independent of the etiology of hyperprolactinemia. The migraine phenotype was the most prevalent (66.6%). Medications used in the treatment of headache not changed during the study. The first line of treatment of hyperprolactinemia was dopaminergic agonists. In the last reevaluation, PRL level under treatment was within the reference range in 54.7% of the cases, and it was observed complete or partial resolution of the headache in 75% of the cases. The median PRL at this time in patients with complete headache resolution was 17 ng/mL, in those who reported partial recovery was 21 ng/mL, and in those in whom the headache did not change was 66 ng/mL, with a significant difference between the group with complete headache resolution vs. the group with unchanged headache (p=0.022). In the cases with complete headache resolution, the median fall on PRL levels was 89% and in those cases with partial headache resolution 86%, both significantly different (p<0.001) from the fall in the cases with an unchanged headache. Conclusion: Data allow us to conclude that, in this series, in the majority of cases the reduction in the level of PRL was followe3d by cessation or relief of the pain. |
id |
ABNEURO-1_25c8d7ca961aa5040be5f8b1a1fff1aa |
---|---|
oai_identifier_str |
oai:scielo:S0004-282X2020000100028 |
network_acronym_str |
ABNEURO-1 |
network_name_str |
Arquivos de neuro-psiquiatria (Online) |
repository_id_str |
|
spelling |
Resolution of headache after reduction of prolactin levels in hyperprolactinemic patientsheadachepituitary adenomasprolactinhyperprolactinemiadopaminergic agonistAbstract Prolactin (PRL) secreting adenomas are associated with high incidence of headache. The role of hyperprolactinemia in the headache context is not clear, nor is the effect of its treatment on headache. Methods: The present longitudinal study evaluated hyperprolactinemic patients (69), in terms of presence and characteristics of headache before and after hyperprolactinemia treatment. Results: Headache was reported by 45 (65.2%) patients, independent of the etiology of hyperprolactinemia. The migraine phenotype was the most prevalent (66.6%). Medications used in the treatment of headache not changed during the study. The first line of treatment of hyperprolactinemia was dopaminergic agonists. In the last reevaluation, PRL level under treatment was within the reference range in 54.7% of the cases, and it was observed complete or partial resolution of the headache in 75% of the cases. The median PRL at this time in patients with complete headache resolution was 17 ng/mL, in those who reported partial recovery was 21 ng/mL, and in those in whom the headache did not change was 66 ng/mL, with a significant difference between the group with complete headache resolution vs. the group with unchanged headache (p=0.022). In the cases with complete headache resolution, the median fall on PRL levels was 89% and in those cases with partial headache resolution 86%, both significantly different (p<0.001) from the fall in the cases with an unchanged headache. Conclusion: Data allow us to conclude that, in this series, in the majority of cases the reduction in the level of PRL was followe3d by cessation or relief of the pain.Academia Brasileira de Neurologia - ABNEURO2020-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2020000100028Arquivos de Neuro-Psiquiatria v.78 n.1 2020reponame:Arquivos de neuro-psiquiatria (Online)instname:Academia Brasileira de Neurologiainstacron:ABNEURO10.1590/0004-282x20190143info:eu-repo/semantics/openAccessOLIVEIRA,Miriam da CostaBAREA,Liselotte MenkeHORN,Andreia Peres KleinONGARATTI,Bárbara RobertaSOARES,José Otávio DworzekiARAUJO,BrunaSANTOS,Tainá Mafalda dosRECH,Carolina LeãesPEREIRA-LIMA,Júlia Fernanda Semmelmanneng2020-02-11T00:00:00Zoai:scielo:S0004-282X2020000100028Revistahttp://www.scielo.br/anphttps://old.scielo.br/oai/scielo-oai.php||revista.arquivos@abneuro.org1678-42270004-282Xopendoar:2020-02-11T00:00Arquivos de neuro-psiquiatria (Online) - Academia Brasileira de Neurologiafalse |
dc.title.none.fl_str_mv |
Resolution of headache after reduction of prolactin levels in hyperprolactinemic patients |
title |
Resolution of headache after reduction of prolactin levels in hyperprolactinemic patients |
spellingShingle |
Resolution of headache after reduction of prolactin levels in hyperprolactinemic patients OLIVEIRA,Miriam da Costa headache pituitary adenomas prolactin hyperprolactinemia dopaminergic agonist |
title_short |
Resolution of headache after reduction of prolactin levels in hyperprolactinemic patients |
title_full |
Resolution of headache after reduction of prolactin levels in hyperprolactinemic patients |
title_fullStr |
Resolution of headache after reduction of prolactin levels in hyperprolactinemic patients |
title_full_unstemmed |
Resolution of headache after reduction of prolactin levels in hyperprolactinemic patients |
title_sort |
Resolution of headache after reduction of prolactin levels in hyperprolactinemic patients |
author |
OLIVEIRA,Miriam da Costa |
author_facet |
OLIVEIRA,Miriam da Costa BAREA,Liselotte Menke HORN,Andreia Peres Klein ONGARATTI,Bárbara Roberta SOARES,José Otávio Dworzeki ARAUJO,Bruna SANTOS,Tainá Mafalda dos RECH,Carolina Leães PEREIRA-LIMA,Júlia Fernanda Semmelmann |
author_role |
author |
author2 |
BAREA,Liselotte Menke HORN,Andreia Peres Klein ONGARATTI,Bárbara Roberta SOARES,José Otávio Dworzeki ARAUJO,Bruna SANTOS,Tainá Mafalda dos RECH,Carolina Leães PEREIRA-LIMA,Júlia Fernanda Semmelmann |
author2_role |
author author author author author author author author |
dc.contributor.author.fl_str_mv |
OLIVEIRA,Miriam da Costa BAREA,Liselotte Menke HORN,Andreia Peres Klein ONGARATTI,Bárbara Roberta SOARES,José Otávio Dworzeki ARAUJO,Bruna SANTOS,Tainá Mafalda dos RECH,Carolina Leães PEREIRA-LIMA,Júlia Fernanda Semmelmann |
dc.subject.por.fl_str_mv |
headache pituitary adenomas prolactin hyperprolactinemia dopaminergic agonist |
topic |
headache pituitary adenomas prolactin hyperprolactinemia dopaminergic agonist |
description |
Abstract Prolactin (PRL) secreting adenomas are associated with high incidence of headache. The role of hyperprolactinemia in the headache context is not clear, nor is the effect of its treatment on headache. Methods: The present longitudinal study evaluated hyperprolactinemic patients (69), in terms of presence and characteristics of headache before and after hyperprolactinemia treatment. Results: Headache was reported by 45 (65.2%) patients, independent of the etiology of hyperprolactinemia. The migraine phenotype was the most prevalent (66.6%). Medications used in the treatment of headache not changed during the study. The first line of treatment of hyperprolactinemia was dopaminergic agonists. In the last reevaluation, PRL level under treatment was within the reference range in 54.7% of the cases, and it was observed complete or partial resolution of the headache in 75% of the cases. The median PRL at this time in patients with complete headache resolution was 17 ng/mL, in those who reported partial recovery was 21 ng/mL, and in those in whom the headache did not change was 66 ng/mL, with a significant difference between the group with complete headache resolution vs. the group with unchanged headache (p=0.022). In the cases with complete headache resolution, the median fall on PRL levels was 89% and in those cases with partial headache resolution 86%, both significantly different (p<0.001) from the fall in the cases with an unchanged headache. Conclusion: Data allow us to conclude that, in this series, in the majority of cases the reduction in the level of PRL was followe3d by cessation or relief of the pain. |
publishDate |
2020 |
dc.date.none.fl_str_mv |
2020-01-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2020000100028 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2020000100028 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.1590/0004-282x20190143 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Academia Brasileira de Neurologia - ABNEURO |
publisher.none.fl_str_mv |
Academia Brasileira de Neurologia - ABNEURO |
dc.source.none.fl_str_mv |
Arquivos de Neuro-Psiquiatria v.78 n.1 2020 reponame:Arquivos de neuro-psiquiatria (Online) instname:Academia Brasileira de Neurologia instacron:ABNEURO |
instname_str |
Academia Brasileira de Neurologia |
instacron_str |
ABNEURO |
institution |
ABNEURO |
reponame_str |
Arquivos de neuro-psiquiatria (Online) |
collection |
Arquivos de neuro-psiquiatria (Online) |
repository.name.fl_str_mv |
Arquivos de neuro-psiquiatria (Online) - Academia Brasileira de Neurologia |
repository.mail.fl_str_mv |
||revista.arquivos@abneuro.org |
_version_ |
1754212785934303232 |